LABD Short Volume

Direxion Daily S&P Biotech Bear 3X ETF (LABD) operates in the Financial Services sector, specifically the Asset Management - Leveraged industry, with a market capitalization near $16.6M, listed on AMEX, carrying a beta of -3.32 to the broader market. The Direxion Daily S&P Biotech Bull and Bear 3X ETFs are designed to deliver daily investment returns reflecting triple (300%) the performance of the S&P Biotechnology Select Industry Index, or triple its inverse (opposite) performance, before factoring in any fees or expenses. public since 2015-05-28.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-08-14
Short Volume
3.4M
Total Volume
7.3M
Short %
46.64%
30-Day Avg Short %
43.23%

Showing 30 days of FINRA short volume data for Direxion Daily S&P Biotech Bear 3X ETF.

Learn how short volume is reported and how to read the data →

Frequently asked LABD short volume questions

What is the daily LABD short volume?
As of Aug 14, 2026, Direxion Daily S&P Biotech Bear 3X ETF (LABD) short volume is 3.4M shares against 7.3M total reported volume, or 46.64% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is LABD short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does LABD short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.